Synthesis of N1'-([18F]fluoroethyl)naltrindole ([18F]FEtNTI): A radioligand for positron emission tomographic studies of delta opioid receptors

Journal of Labelled Compounds and Radiopharmaceuticals

Volumn 42, Issue 1, 1999, Pages 43-54

  Mathews, William B ^a   Kinter, Chris M ^b   Palma, James ^b   Daniels, Robert V ^b   Ravert, Hayden T ^a   Dannals, Robert F ^a,c   Lever, John R ^a,c,d  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNITED STATES NAVAL ACADEMY   (United States)

^c JOHNS HOPKINS UNIVERSITY   (United States)

^d JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Delta opioid receptor; Fluorine 18; Naltrindole; Positron emission tomography

Indexed keywords

ELECTRONS; FLUORINE; FLUORINE COMPOUNDS; POSITRONS; SULFUR COMPOUNDS;

DELTA-OPIOID RECEPTOR; FLUORINE-18; NALTREXONE; NALTRINDOLE; NUCLEOPHILIC DISPLACEMENT; POSITRON EMISSION; RADIOLABELLING; RADIOLIGANDS; RECEPTOR ANTAGONISTS; TOMOGRAPHIC;

POSITRON EMISSION TOMOGRAPHY;

BENZYL DERIVATIVE; DELTA OPIATE RECEPTOR; FLUORINE 18; NALTREXONE; NALTRINDOLE; PHENOL DERIVATIVE; RADIOLIGAND;

ARTICLE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; ISOTOPE LABELING; POSITRON EMISSION TOMOGRAPHY; SYNTHESIS;

EID: 0032902938     PISSN: 03624803     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1099-1344(199901)42:1<43::AID-JLCR165>3.0.CO;2-2     Document Type: Article

References (13)

1. Lever J.R., Scheffel U., Kinter C.M., Ravert H.T., Dannals R.F., Wagner H.N., Jr., and Frost J.J. - Eur. J. Pharmacol. 216: 459 (1992).
2. Lever J.R., Kinter C.M., Ravert H.T., Musachio J.L., Mathews W.B., and Dannals R.F. - J. Labelled Compds. Radiopharm. 26: 137 (1995).
3. Smith J.S., Zubieta J.K., Price J.C., Madar I., Lever J.R., Kinter C.M., Ravert H.T., Dannals R.F., and Frost J.J. - Soc. Neurosci. Abstr. 20: 1384 (1994).
4. Madar I., Lever J.R., Kinter C.M., Scheffel U., Ravert H.T., Musachio J.L., Mathews W.B., Dannals R.F., and Frost J.J. - Synapse 24: 19 (1996).
5. Madar I., Lesser R.P., Krauss G., Zubieta J.K., Lever J.R., Kinter C.M., Ravert H.T., Musachio J.L., Mathews W.B., Dannals R.F., and Frost J.J. -Ann. Neurol. 41: 358 (1997).
6. Arcari M., Aveta R., Brandt A., Cecchetelli L., Corsi G.B., and Solinas F. - Il Farmaco 47: 405 (1992).
7. Portoghese P.S., Sultana M., and Takemori A.E. - J. Med. Chem. 33: 1714 (1990).
8. Kinter C.M. and Lever J.R. - Nucl. Med. Biol. 22: 599 (1995).
9. Lever J.R. and Johnson S.M. - J. Labelled Compds. Radiopharm. 39: 115 (1997).
10. Mathews W.B., Kinter C.M., Palma J., Daniels R.V., Ravert H.T., Scheffel U., McCallister S.L., Chapman S.A., Finley P.A., Dannals R.F., and Lever J.R. - J. Nucl. Med. 39S: 21P (1998).
11. Akgün E., Sajjad M., Arnett C.D., and Portoghese P.S. - Abstracts of the 214th American Chemical Society National Meeting, Las Vegas, NV, September 1997: MEDI 235.
12. Pelletier S.W. - Chem. Ind. 1034 (1953).
13. Hamacher K., Coenen H.H., and Stöcklin G. - J. Nucl. Med. 27: 235 (1986).